SCHEDULE OF STATEMENT OF OPERATIONS ITEMS TO DISCONTINUED OPERATIONS (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
(BENEFIT) PROVISION FOR INCOME TAXES		$ 619,545	$ 100,000	$ 619,545
LOSS FROM DISCONTINUED OPERATIONS OF NANOSYNEX, LTD.		159,507		(683,008)
Loss attributable to noncontrolling interest		(38,526)		(343,038)
NET LOSS ATTRIBUTABLE TO STOCKHOLDERS		(460,038)	(100,000)	(1,302,553)
NanoSynex [Member]
Research and development		81,640		869,064
Total expenses		81,640		869,064
Loss on disposal of discontinued operations		4,479,010		4,479,010
(BENEFIT) PROVISION FOR INCOME TAXES		(150,369)		(357,757)
LOSS FROM DISCONTINUED OPERATIONS OF NANOSYNEX, LTD.		(4,410,281)		(4,990,317)
Loss attributable to noncontrolling interest		(1,276,969)		(1,578,481)
NET LOSS ATTRIBUTABLE TO STOCKHOLDERS		(3,133,312)		(3,411,836)
Parent Company [Member]
Net product sales		426,920		3,661,121
Total revenues		426,920		3,661,121
Cost of product sales		269,747		2,551,114
General and administrative		26,346		610,559
Research and development		2,612		206,819
Sales and marketing		37,288		405,626
Total expenses		335,993		3,774,118
Loss on disposal of equipment held for lease				63,302
Other expense (income), net		149		(4,898)
Loss on fixed asset disposal				300
Total other expense (income), net		149		58,704
INCOME (LOSS) FROM DISCONTINUED OPERATIONS OF QUALIGEN, INC.		90,778		(171,701)
Gain on sale of Qualigen, Inc.		3,859,465		3,859,465
INCOME (LOSS) FROM DISCONTINUED OPERATIONS OF QUALIGEN, INC.		3,950,243		3,687,764
LOSS FROM DISCONTINUED OPERATIONS OF NANOSYNEX, LTD.		90,778		(171,701)
NET LOSS ATTRIBUTABLE TO STOCKHOLDERS		$ 3,950,243	$ (100,000)	$ 3,687,764